Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | The future of radiation therapy for bladder cancer

Sophia Kamran • 17 Feb 2022
GU Cancers 2022
Bladder Cancer Genitourinary Cancer

Sophia Kamran, MD, Massachusetts General Hospital, Boston, MA, talks on the future of radiation therapy for urothelial carcinoma, including hypofractionated radiation therapy, adaptive radiation therapy and personalizing radiation therapy. Additionally, radiation in combination with immunotherapy and other novel therapies is discussed. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.

More from Sophia Kamran

2:44
The role of radiation in managing high-risk localized prostate cancer
Sophia Kamran • 26 Jan 2024
3:09
How can radiotherapy make prostate cancer more immunogenic?
Sophia Kamran • 26 Jan 2024
3:04
Evaluating the role of radiotherapy in primary and metastatic RCC
Sophia Kamran • 26 Jan 2024
2:56
Computational genomic approaches to treatment of genitourinary cancers
Sophia Kamran • 3 Nov 2022

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals